CStone Pharmaceuticals logo

2616 - CStone Pharmaceuticals News Story

HK$9.59 -0.3  -2.6%

Last Trade - 9:08am

Sector
Healthcare
Size
Mid Cap
Market Cap £1.09bn
Enterprise Value £821.4m
Revenue £126.8m
Position in Universe 860th / 6152

BRIEF-Cstone Pharmaceuticals Posts FY Revenue Of RMB1.04 Billion

Thu 25th March, 2021 3:10pm
March 25 (Reuters) - CStone Pharmaceuticals  2616.HK :
    * FY REVENUE RMB1.04 BILLION
    * LOSS FOR YEAR RMB1.22 BILLION VERSUS LOSS OF RMB2.31
BILLION
    * EXPECT TO RECEIVE FIVE NEW DRUG APPLICATION APPROVALS IN
TOTAL
IN 2021

Source text for Eikon:  urn:newsml:reuters.com:*:nHKSbBWddK
Further company coverage:  2616.HK 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.